FATTA, ERIKA

FATTA, ERIKA  

Universita' degli Studi di MILANO  

Risultati 1 - 20 di 33 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Baseline alt and ferritin predict histological findings in NAFLD 1-apr-2007 A.L FracanzaniL. ValentiE. FattaC. BertelliS. Fargion + Article (author) -
Baseline alt and ferritin predict histological findings in NAFLD 1-gen-2007 A.L. FracanzaniL. ValentiC. BertelliE. FattaS. Fargion + Article (author) -
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 1-ott-2008 M. SampietroA.L. FracanzaniL. ValentiC. BertelliE. FattaD. BignaminiD. TavazziS. Fargion Article (author) -
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 1-ott-2008 M. SampietroA.L. FracanzaniL. ValentiC. BertelliE. FattaD. BignaminiD. TavazziS. Fargion Article (author) -
Contrast-enhanced ultrasonography (CEUS) and spiral computed tomography (CT) in the assessement of efficacy of percutaneous ablation treatments of hepatocellular carcinoma in cirrhosis 1-gen-2008 A.L FracanzaniA. MaraschiC. BertelliE. FattaS. Fargion + Article (author) -
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients 1-gen-2004 L. ValentiT. De FeoA.L. FracanzaniE. FattaG. RossiG. FiorelliS. Fargion + Article (author) -
Effectiveness of entecavir for NUC-naïve, HBeAg-negative chronic hepatitis B patients in clinical practice : a 2-year multicenter cohort study in 311 patients 1-apr-2010 P. LamperticoE. FattaS. R. FargionM. Colombo + Article (author) -
Effectiveness of Entecavir for NUC-naïve, HBeAg-negative chronic hepatitis B patients in clinical practice : a 2-year multicenter cohort study in 311 patients 1-feb-2010 P. LamperticoE. FattaS. R. FargionM. Colombo + Article (author) -
Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients : A large multicenter cohort study in clinical practice 1-gen-2009 P. LamperticoM. ViganòF. FacchettiS.R. FargionE. FattaM.A. IavaroneM. Colombo + Article (author) -
Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice 1-gen-2008 P. LamperticoM. ViganòF. FacchettiS. FargionE. FattaM. Colombo + Article (author) -
Effectiveness of entecavir for the treatment of nuc-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice 1-gen-2009 P. LamperticoM. ViganòF. FacchettiS.R. FargionE. FattaM.A. IavaroneM. Colombo + Article (author) -
Entecavir for nuc-naïve chronic hepatitis b patients in clinical practice : long-term effectiveness from a large multicenter cohort study in 376 patients 1-mar-2010 P. LamperticoM. ViganòS. R. FargionE. FattaM. Colombo + Article (author) -
Entecavir for nuc-naïve chronic hepatitis B patients in clinical practice : long-term effectiveness from a large multicenter cohort study in 376 patients 1-gen-2009 P. LamperticoM. ViganòF. FacchettiS. FargionE. FattaM. Colombo + Article (author) -
Entecavir is an effective treatment for NUC-naive chronic hepatitis B patients in clinical practice : 48-week data from a large multicenter cohort study 1-gen-2009 P. LamperticoM. ViganòF. FacchettiS. FargionE. FattaM. IavaroneM. Colombo + Article (author) -
Evaluation of patients with NAFLD with or without increased ALT 1-gen-2008 A.L. FracanzaniL. ValentiC. BertelliE. FattaS. Fargion + Article (author) -
Ferro, steatosi e... 1-ott-2009 E. PulixiD. BignaminiE. FattaC. BertelliA.L. FracanzaniL. ValentiS. Fargion + Article (author) -
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 1-ott-2008 L. ValentiP. DongiovanniE. FattaD. BignaminiS. FargionA.L. Fracanzani + Article (author) -
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 1-ott-2008 L. ValentiC. BertelliP. DongiovanniE. FattaD. BignaminiS. FargionA.L. Fracanzani + Article (author) -
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 27-gen-2022 Cinque F.Cespiati A.Lombardi R.Costantino A.Maffi G.Alletto F.Colavolpe L.Francione P.Oberti G.Fatta E.Bertelli C.Sigon G.Dongiovanni P.Fargion S.Fracanzani A. L. + Article (author) -
Iron depletion by phlebotomy improves liver transaminases in patients with nonalcoholic fatty liver disease : a propensity score adjusted analysis 1-ott-2008 L. ValentiA.L. FracanzaniE. FattaP. DongiovanniS. Fargion + Article (author) -